688373 盟科藥業
按盤價 
5.890 +0.650 (+12.405%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -11.074 | -74.976 | -69.243 | -41.120 | -26.660 |
| 總資產報酬率 ROA (%) | -3.103 | -31.091 | -43.686 | -31.593 | -20.532 |
| 投入資產回報率 ROIC (%) | -3.752 | -36.430 | -49.074 | -33.692 | -21.557 | 邊際利潤分析 |
| 銷售毛利率 (%) | 85.604 | 84.813 | 82.801 | 81.608 | 81.699 |
| 營業利潤率 (%) | -50.951 | -172.864 | -333.522 | -452.655 | -462.460 |
| 息稅前利潤/營業總收入 (%) | -42.264 | -168.251 | -323.228 | -448.462 | -435.981 |
| 淨利潤/營業總收入 (%) | -51.008 | -170.422 | -338.306 | -463.914 | -456.987 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 108.291 | 103.429 | 103.870 | 107.841 | 121.401 |
| 價值變動淨收益/利潤總額(%) | -7.001 | -2.643 | -3.931 | -8.032 | -8.394 |
| 營業外收支淨額/利潤總額(%) | 0.000 | 0.200 | 0.005 | 1.024 | -1.200 | 償債能力分析 |
| 流動比率 (X) | 2.068 | 2.774 | 3.526 | 7.715 | 11.906 |
| 速動比率 (X) | 1.914 | 2.550 | 3.277 | 7.441 | 11.716 |
| 資產負債率 (%) | 73.149 | 70.849 | 48.304 | 28.630 | 18.906 |
| 帶息債務/全部投入資本 (%) | 55.181 | 54.294 | 30.632 | 13.112 | 9.154 |
| 股東權益/帶息債務 (%) | 59.078 | 64.642 | 193.434 | 602.728 | 918.363 |
| 股東權益/負債合計 (%) | 36.706 | 41.145 | 107.021 | 249.282 | 428.927 |
| 利息保障倍數 (X) | -4.865 | -33.922 | -31.344 | -50.535 | -20.766 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 83.028 | 88.665 | 74.415 | 65.595 | 46.745 |
| 存貨周轉天數 (天) | 703.458 | 862.647 | 726.712 | 640.488 | 671.209 |
| 備註： | 即時報價更新時間為 25/08/2026 15:39 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
